loader
Please Wait
Applying Filters...
menu
    • menu

    Digital Content for Tenapanor

    Client Email Product
    Polpharma is a Polish CDMO of APIs and a significant European API producer, delivering products to companies worldwide.

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-09-09

    Virtual Booth

    Contact Supplier

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-09-09

    Virtual Booth

    Contact Supplier

    Menu

    Tenapanor

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Ardelyx To Participate At Cantor Global Healthcare Conference
    Ardelyx To Participate At Cantor Global Healthcare Conference

    05 Sep 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/09/05/2941309/0/en/Ardelyx-to-Participate-at-the-2024-Cantor-Global-Healthcare-Conference.html

    GLOBENEWSWIRE
    05 Sep 2024
    Share Share
    Ardelyx Publishes XPHOZAH® Trial Summaries In Medical Journal
    Ardelyx Publishes XPHOZAH® Trial Summaries In Medical Journal

    31 Jul 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/07/31/2921836/0/en/Ardelyx-Announces-Publication-of-Two-Plain-Language-Summaries-from-XPHOZAH-tenapanor-Clinical-Trials-in-Current-Medical-Research-and-Opinion.html

    GLOBENEWSWIRE
    31 Jul 2024
    Share Share
    Ardelyx sues US health department over kidney disease drug
    Ardelyx sues US health department over kidney disease drug

    18 Jul 2024

    // PRESS RELEASE

    https://ir.ardelyx.com/news-releases/news-release-details/fda-approves-xphozahr-tenapanor-first-class-phosphate-absorption

    PRESS RELEASE
    18 Jul 2024
    Share Share
    Ardelyx Presents IBSRELA IBS-C Data At DDW 2024
    Ardelyx Presents IBSRELA IBS-C Data At DDW 2024

    21 May 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/05/21/2885550/0/en/Ardelyx-Presents-Additional-Data-at-the-2024-Digestive-Disease-Week-Conference-on-IBSRELA-tenapanor-a-First-In-Class-Treatment-for-IBS-C-in-Adults.html

    GLOBENEWSWIRE
    21 May 2024
    Share Share
    Ardelyx Presents Additional XPHOZAH Data At NKF 2024
    Ardelyx Presents Additional XPHOZAH Data At NKF 2024

    16 May 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/05/16/2883372/0/en/Ardelyx-Presents-Additional-Data-at-the-NKF-2024-Spring-Clinical-Meetings-on-XPHOZAH-tenapanor.html

    GLOBENEWSWIRE
    16 May 2024
    Share Share
    Ardelyx To Present IBSRELA Data At Digestive Disease Week 2024
    Ardelyx To Present IBSRELA Data At Digestive Disease Week 2024

    07 May 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/05/07/2876706/0/en/Ardelyx-to-Present-Additional-Data-Supporting-First-In-Class-IBSRELA-tenapanor-for-Adults-with-Irritable-Bowel-Syndrome-with-Constipation-at-the-2024-Digestive-Disease-Week-Confere.html

    GLOBENEWSWIRE
    07 May 2024
    Share Share